A Phase <scp>II</scp> Trial of Lutikizumab, an Anti–Interleukin‐1α/β Dual Variable Domain Immunoglobulin, in Knee Osteoarthritis Patients With Synovitis

Roy Fleischmann, Marc C. Levesque, Francisco J. Blanco et al.|Arthritis & Rheumatology|2019

Cited by 209